Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Transdermal xenobiotics in newborn skin
Barry Weinberger
, Nazeeh Hanna
,
Charles A. Gropper
, Diane E. Heck
, Debra L. Laskin
, Jeffrey D. Laskin
Icahn School of Medicine at Mount Sinai
Waldman Department of Dermatology
Research output
:
Contribution to journal
›
Review article
›
peer-review
2
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Transdermal xenobiotics in newborn skin'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Transdermal
100%
Xenobiotics
100%
Premature Infant
100%
Newborn Skin
100%
Topical Agents
40%
Public Health Risk
20%
Analgesia
20%
Newborn Infant
20%
Safe Dose
20%
Airway Hyperresponsiveness
20%
Allergic Diseases
20%
Iodine
20%
Preterm Infants
20%
Antimicrobial
20%
Antisepsis
20%
Medical Equipment
20%
Skin Barrier
20%
Epidermis
20%
Rash
20%
Systemic Medications
20%
Fully Developed
20%
Hypothalamic-pituitary Axis
20%
GloVe
20%
Methylxanthines
20%
Hospitalised Infants
20%
Systemic Absorption
20%
Skin Exposure
20%
Skin Moisturization
20%
Systemic Effects
20%
Analgesic Agents
20%
Povidone-iodine (PVP-I)
20%
Natural Rubber Latex
20%
Methemoglobinemia
20%
Transdermal Administration
20%
Common Agents
20%
Steroid Cream
20%
Topical Analgesics
20%
Solvent Barriers
20%
Eutectic Mixture of Local Anesthetics
20%
Medicine and Dentistry
Prematurity
100%
Neonatal Infant
100%
Transdermal
100%
Xenobiotics
100%
Topical Agent
40%
Public Health
20%
Analgesia
20%
Exanthem
20%
Antiinfective Agent
20%
Anodyne
20%
Medical Device
20%
Hypothalamus Hypophysis System
20%
Methemoglobinemia
20%
Methylxanthine
20%
Lidocaine/Prilocaine
20%
Topical Analgesics
20%
Transdermal Drug Administration
20%
Newborn Infant
20%
Nursing and Health Professions
Prematurity
100%
Topical Agent
40%
Tincture of Iodine
40%
Analgesia
20%
Antiinfective Agent
20%
Analgesic Agent
20%
Cream
20%
Rash
20%
Medical Device
20%
Lidocaine Plus Prilocaine
20%
Methylxanthine
20%
Antisepsis
20%
Methemoglobinemia
20%
Transdermal Drug Administration
20%
Public Health
20%
Pharmacology, Toxicology and Pharmaceutical Science
Prematurity
100%
Transdermal
100%
Topical Agent
40%
Antiinfective Agent
20%
Analgesic Agent
20%
Rash
20%
Methemoglobinemia
20%
Methylxanthine
20%
Lidocaine Plus Prilocaine
20%
Topical Analgesics
20%